Questcor surges on buyout; MannKind sinks

Questcor is up on a buyout deal while an FDA review extension is sending MannKind lower.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.